News

ProteLigt R & D Team was named as “Innovation and Entrepreneurship Team” of Jiangsu Province in 2017

2017-12-29

On December 27th, 2017, appraised by Jiangsu Province Personnel Work Leading Group and CPC Jiangsu Provincial Party Committee, ProteLight’s R & D team was finally named as  “Innovation and Entrepreneurship Team” of Jiangsu Province in 2017, which is the only Noble Prize Winner type’s Innovation and Entrepreneurship Team in this appraisal.

Previous article

Dr. Yuxin Chen Received Peptide Application Special Award

Next article

Congratulate to ProteLight for Being Identified as Hi-Tech Enterprise

/news_detail/49.html

■

ProteLight Pharma’s Innovative Antimicrobial Peptide PL-18 Suppository Has Received FDA Approval to Commence Clinical Studies.

—

2024-10-26

■

ProteLight Pharma’s Innovative Antimicrobial Peptide PL-18 Suppository Has Received FDA Approval to Commence Clinical Studies.

■

ProteLight Pharma’s Innovative Antimicrobial Peptide PL-3301 Oral Gel Has Been Granted FDA Approval To Commence Clinical Trials.

■

The publication of a confirmative Phase III clinical study on Peceleganan Spray (project code: PL-5), an innovative antimicrobial peptide developed by ProteLight Pharms, has been released.

■

ProteLight Pharma was selected into the list of “Top 100 Chinese Pharmaceutical Innovative Seed Enterprises in 2023”

■

Congratulations to the company for passing the ISO9001 quality management system certification

■

Antimicrobial Peptide PL-18 Suppository (First-in-class new drug) of ProteLight Pharma Received Clinical Trial Approval from CDE in China